To further investigate the role of CAF-derived DKK1 during tumor progression, we co-injected Dkk1-deficient (Dkk1cKO) or sufficient (DkkWT) CAFs with PyMT tumor cells (1:1 ratio) into the MFP of naive WT recipient mice. The gene discussed is DKK1; the disease is neoplasm.